Olympus Veran Technologies

Olympus Veran Technologies is a medical device company based in St. Louis, Missouri, specializing in advanced technologies for interventional pulmonology. The company focuses on assisting physicians in the early diagnosis and treatment of lung cancer. It was acquired by Olympus Corporation of the Americas in December 2020, enhancing Olympus' respiratory medical device portfolio. The flagship product of Olympus Veran Technologies is the SPiN Thoracic Navigation System®, an FDA-cleared electromagnetic navigation platform. This system improves the accuracy and efficiency of lung cancer diagnosis and includes the proprietary SPiN Perc® technology, which allows for seamless transitions between navigated bronchoscopy and transthoracic needle aspiration (TTNA) in a single procedure. The company’s solutions are designed to help healthcare providers navigate and sample peripheral pulmonary lesions, ultimately improving early detection and patient outcomes in lung cancer care.

• Employees 27
• Founded 2005
• Annual Revenue $100000000
• Total Funding $153600000